Global Acromegaly Market Size, Status and Forecast 2020-2026

May 2020 | 96 pages | ID: G425FE421370EN
QYResearch

Abstracts

This report focuses on the global Acromegaly status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acromegaly development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Novartis
• Aegis Therapeutics
• Chiasma
• Crinetics Pharmaceuticals
• Daewoong Pharmaceutical
• Peptron
• Silence Therapeutics
• Strongbridge Biopharma
• Amryt Pharma
• Foresee Pharmaceuticals
• Glide Pharmaceutical
• Ionis Pharmaceuticals
• Ipsen

Market segment by Type, the product can be split into

• Somatostatin Analogues
• Dopamine Agonists
• Growth Hormone Receptor Antagonists
• Other

Market segment by Application, split into

• Hospitals
• Clinics

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Acromegaly status, future forecast, growth opportunity, key market and key players.
• To present the Acromegaly development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Acromegaly are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acromegaly Revenue
1.4 Market Analysis by Type
  1.4.1 Global Acromegaly Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Somatostatin Analogues
  1.4.3 Dopamine Agonists
  1.4.4 Growth Hormone Receptor Antagonists
  1.4.5 Other
1.5 Market by Application
  1.5.1 Global Acromegaly Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Acromegaly Market Perspective (2015-2026)
2.2 Acromegaly Growth Trends by Regions
  2.2.1 Acromegaly Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Acromegaly Historic Market Share by Regions (2015-2020)
  2.2.3 Acromegaly Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Acromegaly Market Growth Strategy
  2.3.6 Primary Interviews with Key Acromegaly Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Acromegaly Players by Market Size
  3.1.1 Global Top Acromegaly Players by Revenue (2015-2020)
  3.1.2 Global Acromegaly Revenue Market Share by Players (2015-2020)
  3.1.3 Global Acromegaly Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acromegaly Market Concentration Ratio
  3.2.1 Global Acromegaly Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Acromegaly Revenue in 2019
3.3 Acromegaly Key Players Head office and Area Served
3.4 Key Players Acromegaly Product Solution and Service
3.5 Date of Enter into Acromegaly Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Acromegaly Historic Market Size by Type (2015-2020)
4.2 Global Acromegaly Forecasted Market Size by Type (2021-2026)

5 ACROMEGALY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Acromegaly Market Size by Application (2015-2020)
5.2 Global Acromegaly Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Acromegaly Market Size (2015-2020)
6.2 Acromegaly Key Players in North America (2019-2020)
6.3 North America Acromegaly Market Size by Type (2015-2020)
6.4 North America Acromegaly Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Acromegaly Market Size (2015-2020)
7.2 Acromegaly Key Players in Europe (2019-2020)
7.3 Europe Acromegaly Market Size by Type (2015-2020)
7.4 Europe Acromegaly Market Size by Application (2015-2020)

8 CHINA

8.1 China Acromegaly Market Size (2015-2020)
8.2 Acromegaly Key Players in China (2019-2020)
8.3 China Acromegaly Market Size by Type (2015-2020)
8.4 China Acromegaly Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Acromegaly Market Size (2015-2020)
9.2 Acromegaly Key Players in Japan (2019-2020)
9.3 Japan Acromegaly Market Size by Type (2015-2020)
9.4 Japan Acromegaly Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Acromegaly Market Size (2015-2020)
10.2 Acromegaly Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acromegaly Market Size by Type (2015-2020)
10.4 Southeast Asia Acromegaly Market Size by Application (2015-2020)

11 INDIA

11.1 India Acromegaly Market Size (2015-2020)
11.2 Acromegaly Key Players in India (2019-2020)
11.3 India Acromegaly Market Size by Type (2015-2020)
11.4 India Acromegaly Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Acromegaly Market Size (2015-2020)
12.2 Acromegaly Key Players in Central & South America (2019-2020)
12.3 Central & South America Acromegaly Market Size by Type (2015-2020)
12.4 Central & South America Acromegaly Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Novartis
  13.1.1 Novartis Company Details
  13.1.2 Novartis Business Overview and Its Total Revenue
  13.1.3 Novartis Acromegaly Introduction
  13.1.4 Novartis Revenue in Acromegaly Business (2015-2020))
  13.1.5 Novartis Recent Development
13.2 Aegis Therapeutics
  13.2.1 Aegis Therapeutics Company Details
  13.2.2 Aegis Therapeutics Business Overview and Its Total Revenue
  13.2.3 Aegis Therapeutics Acromegaly Introduction
  13.2.4 Aegis Therapeutics Revenue in Acromegaly Business (2015-2020)
  13.2.5 Aegis Therapeutics Recent Development
13.3 Chiasma
  13.3.1 Chiasma Company Details
  13.3.2 Chiasma Business Overview and Its Total Revenue
  13.3.3 Chiasma Acromegaly Introduction
  13.3.4 Chiasma Revenue in Acromegaly Business (2015-2020)
  13.3.5 Chiasma Recent Development
13.4 Crinetics Pharmaceuticals
  13.4.1 Crinetics Pharmaceuticals Company Details
  13.4.2 Crinetics Pharmaceuticals Business Overview and Its Total Revenue
  13.4.3 Crinetics Pharmaceuticals Acromegaly Introduction
  13.4.4 Crinetics Pharmaceuticals Revenue in Acromegaly Business (2015-2020)
  13.4.5 Crinetics Pharmaceuticals Recent Development
13.5 Daewoong Pharmaceutical
  13.5.1 Daewoong Pharmaceutical Company Details
  13.5.2 Daewoong Pharmaceutical Business Overview and Its Total Revenue
  13.5.3 Daewoong Pharmaceutical Acromegaly Introduction
  13.5.4 Daewoong Pharmaceutical Revenue in Acromegaly Business (2015-2020)
  13.5.5 Daewoong Pharmaceutical Recent Development
13.6 Peptron
  13.6.1 Peptron Company Details
  13.6.2 Peptron Business Overview and Its Total Revenue
  13.6.3 Peptron Acromegaly Introduction
  13.6.4 Peptron Revenue in Acromegaly Business (2015-2020)
  13.6.5 Peptron Recent Development
13.7 Silence Therapeutics
  13.7.1 Silence Therapeutics Company Details
  13.7.2 Silence Therapeutics Business Overview and Its Total Revenue
  13.7.3 Silence Therapeutics Acromegaly Introduction
  13.7.4 Silence Therapeutics Revenue in Acromegaly Business (2015-2020)
  13.7.5 Silence Therapeutics Recent Development
13.8 Strongbridge Biopharma
  13.8.1 Strongbridge Biopharma Company Details
  13.8.2 Strongbridge Biopharma Business Overview and Its Total Revenue
  13.8.3 Strongbridge Biopharma Acromegaly Introduction
  13.8.4 Strongbridge Biopharma Revenue in Acromegaly Business (2015-2020)
  13.8.5 Strongbridge Biopharma Recent Development
13.9 Amryt Pharma
  13.9.1 Amryt Pharma Company Details
  13.9.2 Amryt Pharma Business Overview and Its Total Revenue
  13.9.3 Amryt Pharma Acromegaly Introduction
  13.9.4 Amryt Pharma Revenue in Acromegaly Business (2015-2020)
  13.9.5 Amryt Pharma Recent Development
13.10 Foresee Pharmaceuticals
  13.10.1 Foresee Pharmaceuticals Company Details
  13.10.2 Foresee Pharmaceuticals Business Overview and Its Total Revenue
  13.10.3 Foresee Pharmaceuticals Acromegaly Introduction
  13.10.4 Foresee Pharmaceuticals Revenue in Acromegaly Business (2015-2020)
  13.10.5 Foresee Pharmaceuticals Recent Development
13.11 Glide Pharmaceutical
  10.11.1 Glide Pharmaceutical Company Details
  10.11.2 Glide Pharmaceutical Business Overview and Its Total Revenue
  10.11.3 Glide Pharmaceutical Acromegaly Introduction
  10.11.4 Glide Pharmaceutical Revenue in Acromegaly Business (2015-2020)
  10.11.5 Glide Pharmaceutical Recent Development
13.12 Ionis Pharmaceuticals
  10.12.1 Ionis Pharmaceuticals Company Details
  10.12.2 Ionis Pharmaceuticals Business Overview and Its Total Revenue
  10.12.3 Ionis Pharmaceuticals Acromegaly Introduction
  10.12.4 Ionis Pharmaceuticals Revenue in Acromegaly Business (2015-2020)
  10.12.5 Ionis Pharmaceuticals Recent Development
13.13 Ipsen
  10.13.1 Ipsen Company Details
  10.13.2 Ipsen Business Overview and Its Total Revenue
  10.13.3 Ipsen Acromegaly Introduction
  10.13.4 Ipsen Revenue in Acromegaly Business (2015-2020)
  10.13.5 Ipsen Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Acromegaly Key Market Segments
Table 2. Key Players Covered: Ranking by Acromegaly Revenue
Table 3. Ranking of Global Top Acromegaly Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acromegaly Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Somatostatin Analogues
Table 6. Key Players of Dopamine Agonists
Table 7. Key Players of Growth Hormone Receptor Antagonists
Table 8. Key Players of Other
Table 9. Global Acromegaly Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Acromegaly Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Acromegaly Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Acromegaly Market Share by Regions (2015-2020)
Table 13. Global Acromegaly Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Acromegaly Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Acromegaly Market Growth Strategy
Table 19. Main Points Interviewed from Key Acromegaly Players
Table 20. Global Acromegaly Revenue by Players (2015-2020) (Million US$)
Table 21. Global Acromegaly Market Share by Players (2015-2020)
Table 22. Global Top Acromegaly Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acromegaly as of 2019)
Table 23. Global Acromegaly by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Acromegaly Product Solution and Service
Table 26. Date of Enter into Acromegaly Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Acromegaly Market Size by Type (2015-2020) (Million US$)
Table 29. Global Acromegaly Market Size Share by Type (2015-2020)
Table 30. Global Acromegaly Revenue Market Share by Type (2021-2026)
Table 31. Global Acromegaly Market Size Share by Application (2015-2020)
Table 32. Global Acromegaly Market Size by Application (2015-2020) (Million US$)
Table 33. Global Acromegaly Market Size Share by Application (2021-2026)
Table 34. North America Key Players Acromegaly Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Acromegaly Market Share (2019-2020)
Table 36. North America Acromegaly Market Size by Type (2015-2020) (Million US$)
Table 37. North America Acromegaly Market Share by Type (2015-2020)
Table 38. North America Acromegaly Market Size by Application (2015-2020) (Million US$)
Table 39. North America Acromegaly Market Share by Application (2015-2020)
Table 40. Europe Key Players Acromegaly Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Acromegaly Market Share (2019-2020)
Table 42. Europe Acromegaly Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Acromegaly Market Share by Type (2015-2020)
Table 44. Europe Acromegaly Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Acromegaly Market Share by Application (2015-2020)
Table 46. China Key Players Acromegaly Revenue (2019-2020) (Million US$)
Table 47. China Key Players Acromegaly Market Share (2019-2020)
Table 48. China Acromegaly Market Size by Type (2015-2020) (Million US$)
Table 49. China Acromegaly Market Share by Type (2015-2020)
Table 50. China Acromegaly Market Size by Application (2015-2020) (Million US$)
Table 51. China Acromegaly Market Share by Application (2015-2020)
Table 52. Japan Key Players Acromegaly Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Acromegaly Market Share (2019-2020)
Table 54. Japan Acromegaly Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Acromegaly Market Share by Type (2015-2020)
Table 56. Japan Acromegaly Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Acromegaly Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Acromegaly Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Acromegaly Market Share (2019-2020)
Table 60. Southeast Asia Acromegaly Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Acromegaly Market Share by Type (2015-2020)
Table 62. Southeast Asia Acromegaly Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Acromegaly Market Share by Application (2015-2020)
Table 64. India Key Players Acromegaly Revenue (2019-2020) (Million US$)
Table 65. India Key Players Acromegaly Market Share (2019-2020)
Table 66. India Acromegaly Market Size by Type (2015-2020) (Million US$)
Table 67. India Acromegaly Market Share by Type (2015-2020)
Table 68. India Acromegaly Market Size by Application (2015-2020) (Million US$)
Table 69. India Acromegaly Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Acromegaly Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Acromegaly Market Share (2019-2020)
Table 72. Central & South America Acromegaly Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Acromegaly Market Share by Type (2015-2020)
Table 74. Central & South America Acromegaly Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Acromegaly Market Share by Application (2015-2020)
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Product
Table 79. Novartis Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 80. Novartis Recent Development
Table 81. Aegis Therapeutics Company Details
Table 82. Aegis Therapeutics Business Overview
Table 83. Aegis Therapeutics Product
Table 84. Aegis Therapeutics Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 85. Aegis Therapeutics Recent Development
Table 86. Chiasma Company Details
Table 87. Chiasma Business Overview
Table 88. Chiasma Product
Table 89. Chiasma Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 90. Chiasma Recent Development
Table 91. Crinetics Pharmaceuticals Company Details
Table 92. Crinetics Pharmaceuticals Business Overview
Table 93. Crinetics Pharmaceuticals Product
Table 94. Crinetics Pharmaceuticals Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 95. Crinetics Pharmaceuticals Recent Development
Table 96. Daewoong Pharmaceutical Company Details
Table 97. Daewoong Pharmaceutical Business Overview
Table 98. Daewoong Pharmaceutical Product
Table 99. Daewoong Pharmaceutical Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 100. Daewoong Pharmaceutical Recent Development
Table 101. Peptron Company Details
Table 102. Peptron Business Overview
Table 103. Peptron Product
Table 104. Peptron Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 105. Peptron Recent Development
Table 106. Silence Therapeutics Company Details
Table 107. Silence Therapeutics Business Overview
Table 108. Silence Therapeutics Product
Table 109. Silence Therapeutics Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 110. Silence Therapeutics Recent Development
Table 111. Strongbridge Biopharma Business Overview
Table 112. Strongbridge Biopharma Product
Table 113. Strongbridge Biopharma Company Details
Table 114. Strongbridge Biopharma Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 115. Strongbridge Biopharma Recent Development
Table 116. Amryt Pharma Company Details
Table 117. Amryt Pharma Business Overview
Table 118. Amryt Pharma Product
Table 119. Amryt Pharma Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 120. Amryt Pharma Recent Development
Table 121. Foresee Pharmaceuticals Company Details
Table 122. Foresee Pharmaceuticals Business Overview
Table 123. Foresee Pharmaceuticals Product
Table 124. Foresee Pharmaceuticals Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 125. Foresee Pharmaceuticals Recent Development
Table 126. Glide Pharmaceutical Company Details
Table 127. Glide Pharmaceutical Business Overview
Table 128. Glide Pharmaceutical Product
Table 129. Glide Pharmaceutical Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 130. Glide Pharmaceutical Recent Development
Table 131. Ionis Pharmaceuticals Company Details
Table 132. Ionis Pharmaceuticals Business Overview
Table 133. Ionis Pharmaceuticals Product
Table 134. Ionis Pharmaceuticals Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 135. Ionis Pharmaceuticals Recent Development
Table 136. Ipsen Company Details
Table 137. Ipsen Business Overview
Table 138. Ipsen Product
Table 139. Ipsen Revenue in Acromegaly Business (2015-2020) (Million US$)
Table 140. Ipsen Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Acromegaly Market Share by Type: 2020 VS 2026
Figure 2. Somatostatin Analogues Features
Figure 3. Dopamine Agonists Features
Figure 4. Growth Hormone Receptor Antagonists Features
Figure 5. Other Features
Figure 6. Global Acromegaly Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Acromegaly Report Years Considered
Figure 10. Global Acromegaly Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Acromegaly Market Share by Regions: 2020 VS 2026
Figure 12. Global Acromegaly Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Acromegaly Market Share by Players in 2019
Figure 15. Global Top Acromegaly Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acromegaly as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Acromegaly Revenue in 2019
Figure 17. North America Acromegaly Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Acromegaly Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Acromegaly Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Acromegaly Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Acromegaly Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Acromegaly Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Acromegaly Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Novartis Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 26. Aegis Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Aegis Therapeutics Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 28. Chiasma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Chiasma Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 30. Crinetics Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Crinetics Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 32. Daewoong Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Daewoong Pharmaceutical Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 34. Peptron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Peptron Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 36. Silence Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Silence Therapeutics Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 38. Strongbridge Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Strongbridge Biopharma Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 40. Amryt Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Amryt Pharma Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 42. Foresee Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Foresee Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 44. Glide Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Glide Pharmaceutical Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 46. Ionis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Ionis Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 48. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Ipsen Revenue Growth Rate in Acromegaly Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed